Focus Partners Wealth lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 42.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 52,282 shares of the real estate investment trust's stock after selling 38,304 shares during the quarter. Focus Partners Wealth's holdings in Healthpeak Properties were worth $1,060,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of DOC. JPMorgan Chase & Co. boosted its position in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after acquiring an additional 4,056,931 shares in the last quarter. Vert Asset Management LLC boosted its position in shares of Healthpeak Properties by 11.1% during the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust's stock valued at $6,167,000 after purchasing an additional 30,461 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Healthpeak Properties by 25.7% in the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust's stock worth $2,213,000 after purchasing an additional 22,300 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its holdings in Healthpeak Properties by 16.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust's stock worth $2,217,000 after purchasing an additional 15,753 shares in the last quarter. Finally, Sterling Capital Management LLC boosted its holdings in shares of Healthpeak Properties by 22.4% during the 4th quarter. Sterling Capital Management LLC now owns 80,157 shares of the real estate investment trust's stock valued at $1,625,000 after buying an additional 14,689 shares in the last quarter. 93.57% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Healthpeak Properties news, CEO Scott M. Brinker bought 2,750 shares of the business's stock in a transaction that occurred on Friday, May 9th. The stock was bought at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the completion of the transaction, the chief executive officer now owns 204,613 shares of the company's stock, valued at $3,558,220.07. This represents a 1.36% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John T. Thomas bought 4,200 shares of Healthpeak Properties stock in a transaction on Monday, April 28th. The shares were acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the completion of the acquisition, the director now owns 813,566 shares of the company's stock, valued at $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders bought 23,987 shares of company stock valued at $422,141 over the last 90 days. Company insiders own 0.23% of the company's stock.
Analysts Set New Price Targets
DOC has been the subject of a number of recent research reports. Evercore ISI lowered their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Argus reissued a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. Wedbush reduced their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Robert W. Baird cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 29th. Finally, Scotiabank reduced their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $23.45.
Read Our Latest Analysis on DOC
Healthpeak Properties Stock Performance
Shares of DOC stock traded down $0.64 during trading hours on Wednesday, reaching $16.86. The company had a trading volume of 9,503,405 shares, compared to its average volume of 5,044,197. The business has a fifty day moving average price of $18.68 and a 200-day moving average price of $19.99. Healthpeak Properties, Inc. has a one year low of $16.83 and a one year high of $23.26. The firm has a market cap of $11.71 billion, a PE ratio of 48.16, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same quarter last year, the company posted $0.45 earnings per share. The firm's quarterly revenue was up 15.9% on a year-over-year basis. Sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently declared a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's dividend payout ratio (DPR) is currently 305.00%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report